Manning & Napier Group, LLC Grifols Sa Transaction History

Manning & Napier Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$10.6 - $13.28 $1.34 Million - $1.68 Million	-126,838 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$10.37 - $12.73 $6,771 - $8,312	653 Added 0.52%	126,838 $1.48 Million
Q4 2021 Jan 27, 2022	SELL	$10.21 - $15.27 $8,933 - $13,361	-875 Reduced 0.69%	126,185 $1.42 Million
Q3 2021 Oct 14, 2021	BUY	$14.07 - $17.3 $6,880 - $8,459	489 Added 0.39%	127,060 $1.86 Million
Q2 2021 Jul 19, 2021	BUY	$16.62 - $18.94 $2.1 Million - $2.4 Million	126,571 New	126,571 $2.2 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Manning & Napier Group, LLC with notifications on news.